MORPHOLOGICAL FEATURES OF KIDNEY DAMAGE IN CHILDREN WITH IGA NEPHROPATHY
Abstract
Background: IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and renal biopsy remains the gold standard for diagnosis and provides valuable information about disease severity and prognosis.
Objective: To evaluate renal biopsy findings in children with IgA nephropathy and analyze associations between morphological lesions and clinical parameters at the time of diagnosis.
Methods: A retrospective observational study included 27 children with biopsy‑proven IgA nephropathy. Renal biopsy specimens were evaluated using light microscopy and immunohistochemistry. Histological lesions were classified according to the Haas classification and Oxford MEST‑C scoring system. Clinical and laboratory parameters were analyzed at the time of biopsy.
Results: IgA nephropathy accounted for 45.8% of nephritic syndrome cases in the cohort. The most common clinical manifestations were asymptomatic microhematuria and hematuria with proteinuria. Mesangial proliferation was observed in 73% of biopsies, segmental glomerulosclerosis in 52%, and tubulointerstitial damage in 10%. Immunohistochemical analysis revealed predominant mesangial IgA deposition accompanied by complement component C3.
Conclusion: Renal biopsy findings in pediatric IgA nephropathy are characterized by mesangial proliferation and immune complex deposition. Oxford MEST‑C classification provides important prognostic information and helps identify children at increased risk of disease progression.
References
KDIGO Glomerular Diseases Work Group. KDIGO clinical practice guideline for the management of glomerular diseases. Kidney International. 2021;100(Suppl 4):S1–S276.
Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for glomerular diseases. Kidney International. 2021;100(4):753–779.
Barbour SJ, Reich HN. Risk stratification in IgA nephropathy. Nature Reviews Nephrology. 2021;17(7):451–463.
Coppo R, Troyanov S, Bellur S, et al. Validation of the Oxford classification of IgA nephropathy in children. Clinical Journal of the American Society of Nephrology. 2021;16(8):1234–1243.
Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy: update and future perspectives. Kidney International Reports. 2022;7(6):1375–1385.
Wyatt RJ, Julian BA. IgA nephropathy in children and adolescents. Pediatric Nephrology. 2022;37(10):2371–2384.
Coppo R, D'Arrigo G. Treatment of IgA nephropathy: recent advances and future strategies. Nature Reviews Nephrology. 2022;18(6):395–414.
Lv J, Zhang H. Pathogenesis and treatment of IgA nephropathy. Annual Review of Medicine. 2022;73:247–260.
Floege J, Amann K. Primary glomerulonephritides. The Lancet. 2023;402(10401):1937–1953.
Reich HN, Troyanov S. Long-term prognosis of IgA nephropathy. Journal of the American Society of Nephrology. 2023;34(2):179–191.
Barratt J, Rovin BH, Zhang H, et al. IgA nephropathy. Nature Reviews Disease Primers. 2023;9(1):18.
Filippone EJ, Farber JL. Contemporary review of IgA nephropathy pathogenesis and treatment. Frontiers in Immunology. 2024;15:1436923.
Vivarelli M, Massella L, Emma F, et al. IPNA clinical practice recommendations for diagnosis and management of IgA nephropathy in children. Pediatric Nephrology. 2024;39(10):2951–2970.
Peruzzi L, Coppo R. IgA nephropathy across the age spectrum: the pediatric perspective. Seminars in Nephrology. 2024;44(4):151386.
Pourpashang P. Application of the international IgA nephropathy prediction tool in pediatric patients. Journal of Nephropharmacology. 2025;14:e12800.
Stamellou E, Floege J. Update on KDIGO guidelines for IgA nephropathy. Kidney International. 2025;107(2):345–356.
Milivojević D, et al. Oxford classification of IgA nephropathy in pediatric cohorts. Life. 2025;15(8):1231–1242.
Alladin-Karan A, et al. Is childhood IgA nephropathy different from adult disease? Clinical Kidney Journal. 2025;18(3):sfad321.
Filippone EJ, Barbour SJ. Biomarkers and prediction models in IgA nephropathy. Kidney International Reports. 2025;10(4):1180–1192.
He Q, Li J, Guan T, et al. AI-based glomerular lesion assessment for renal pathology. Artificial Intelligence in Medicine. 2026;140:102612.